Event JSON
{
"id": "9f481922f6905c127f6dd1e85f17a2a9d720fb4f2a71c5dfd763af57315c1ac7",
"pubkey": "6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"created_at": 1738849618,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/zimmer-biomet-forecasts-2025-profit-134123663.html"
],
[
"subject",
"Zimmer Biomet forecasts 2025 profit below estimates"
],
[
"published_at",
"1738849283"
],
[
"image",
"https://media.zenfs.com/en/reuters-finance.com/9c29cdc4d5bce009c40596db6b768afe"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/reuters-finance.com/9c29cdc4d5bce009c40596db6b768afe"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"Zimmer Biomet Holdings forecast its full-year adjusted profit to be in the range of $8.15 to $8.35 per share, below the average of analysts' expectations of $8.56 per share. The company anticipates a 1.5% to 2% negative impact from currency swings on its revenue this year. However, the company's fourth-quarter profit and revenue both came in slightly above expectations, driven by strong demand for its devices used in hip and knee procedures. The company's hips and knees units reported combined sales of $1.36 billion, up from $1.30 billion a year ago."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r\nhttps://media.zenfs.com/en/reuters-finance.com/9c29cdc4d5bce009c40596db6b768afe\n\nhttps://finance.yahoo.com/news/zimmer-biomet-forecasts-2025-profit-134123663.html",
"sig": "645a0624df51ce739fd0ed9029f4f081605d3e5354e0e34011a6a45f7f20ecea81d47e6abbf80a6147d170ea21e8153cc5755345accbd031be18c2705357a76a"
}